Allison F Christiaansen1, Muhammad A Syed2, Patrick P Ten Eyck3, Stacey M Hartwig1, Lakshmi Durairaj4, Sameer S Kamath2, Steven M Varga1,5,6. 1. Department of Microbiology, University of Iowa, Iowa City, Iowa. 2. Department of Pediatrics, University of Iowa, Iowa City, Iowa. 3. Institute for Clinical and Translational Science, University of Iowa, Iowa City, Iowa. 4. Department of Internal Medicine, University of Iowa, Iowa City, Iowa. 5. Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, Iowa. 6. Department of Pathology, University of Iowa, Iowa City, Iowa.
Abstract
BACKGROUND: Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and pneumonia in children under 1 y of age in the USA. The host immune response is believed to contribute to RSV-induced disease. We hypothesize that severe RSV infection in infants is mediated by insufficient regulation of the host immune response of regulatory T cells (Tregs) resulting in immunopathology. METHODS: Blood and nasal aspirates from 23 RSV-infected and 17 control infants under 1 y of age were collected. Treg frequencies were determined by flow cytometry from peripheral blood mononuclear cells. Analysis of 24 cytokines was measured by multiplex assay on nasal aspirates. RESULTS: We demonstrate that the frequency of activated Tregs is significantly reduced in the peripheral blood of RSV-infected infants compared with age-matched controls. Surprisingly, T helper (Th)17 related cytokines including interleukin (IL)-1β, IL-17A, and IL-23 were associated with a reduction in clinical symptoms of respiratory distress. In addition, the amount of IL-33 protein in nasal washes, a cytokine important in maintaining Treg homeostasis in mucosal tissues, was decreased in RSV-infected children. CONCLUSION: These results suggest that decreased Treg numbers and an inability to properly control the host inflammatory response results in severe RSV infection.
BACKGROUND:Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and pneumonia in children under 1 y of age in the USA. The host immune response is believed to contribute to RSV-induced disease. We hypothesize that severe RSV infection in infants is mediated by insufficient regulation of the host immune response of regulatory T cells (Tregs) resulting in immunopathology. METHODS: Blood and nasal aspirates from 23 RSV-infected and 17 control infants under 1 y of age were collected. Treg frequencies were determined by flow cytometry from peripheral blood mononuclear cells. Analysis of 24 cytokines was measured by multiplex assay on nasal aspirates. RESULTS: We demonstrate that the frequency of activated Tregs is significantly reduced in the peripheral blood of RSV-infectedinfants compared with age-matched controls. Surprisingly, T helper (Th)17 related cytokines including interleukin (IL)-1β, IL-17A, and IL-23 were associated with a reduction in clinical symptoms of respiratory distress. In addition, the amount of IL-33 protein in nasal washes, a cytokine important in maintaining Treg homeostasis in mucosal tissues, was decreased in RSV-infectedchildren. CONCLUSION: These results suggest that decreased Treg numbers and an inability to properly control the host inflammatory response results in severe RSV infection.
Authors: K K Tekkanat; H F Maassab; D S Cho; J J Lai; A John; A Berlin; M H Kaplan; N W Lukacs Journal: J Immunol Date: 2001-03-01 Impact factor: 5.422
Authors: Thomas C Mangodt; Mikhaïl A Van Herck; Sara Nullens; José Ramet; Jozef J De Dooy; Philippe G Jorens; Benedicte Y De Winter Journal: Pediatr Res Date: 2015-08-12 Impact factor: 3.756
Authors: J Loebbermann; H Thornton; L Durant; T Sparwasser; K E Webster; J Sprent; F J Culley; C Johansson; P J Openshaw Journal: Mucosal Immunol Date: 2012-01-11 Impact factor: 7.313
Authors: Chris Schiering; Thomas Krausgruber; Agnieszka Chomka; Anja Fröhlich; Krista Adelmann; Elizabeth A Wohlfert; Johanna Pott; Thibault Griseri; Julia Bollrath; Ahmed N Hegazy; Oliver J Harrison; Benjamin M J Owens; Max Löhning; Yasmine Belkaid; Padraic G Fallon; Fiona Powrie Journal: Nature Date: 2014-07-16 Impact factor: 49.962
Authors: Charles F Schuler; Carrie-Anne Malinczak; Shannon K K Best; Susan B Morris; Andrew J Rasky; Catherine Ptaschinski; Nicholas W Lukacs; Wendy Fonseca Journal: Allergy Date: 2020-05-15 Impact factor: 13.146
Authors: David T Siefker; Luan Vu; Dahui You; Andrew McBride; Ryleigh Taylor; Tamekia L Jones; John DeVincenzo; Stephania A Cormier Journal: Am J Respir Crit Care Med Date: 2020-02-01 Impact factor: 21.405
Authors: Jason P Lynch; Rhiannon B Werder; Zhixuan Loh; Md Al Amin Sikder; Bodie Curren; Vivian Zhang; Matthew J Rogers; Katie Lane; Jennifer Simpson; Stuart B Mazzone; Kirsten Spann; John Hayball; Kerrilyn Diener; Mark L Everard; Christopher C Blyth; Christian Forstner; Paul G Dennis; Nida Murtaza; Mark Morrison; Páraic Ó Cuív; Ping Zhang; Ashraful Haque; Geoffrey R Hill; Peter D Sly; John W Upham; Simon Phipps Journal: J Exp Med Date: 2017-12-22 Impact factor: 14.307
Authors: Thomas H A Ederveen; Gerben Ferwerda; Inge M Ahout; Marloes Vissers; Ronald de Groot; Jos Boekhorst; Harro M Timmerman; Martijn A Huynen; Sacha A F T van Hijum; Marien I de Jonge Journal: Microbiome Date: 2018-01-11 Impact factor: 14.650
Authors: Jorge A Soto; Laura M Stephens; Kody A Waldstein; Gisela Canedo-Marroquín; Steven M Varga; Alexis M Kalergis Journal: Front Immunol Date: 2020-07-17 Impact factor: 7.561